Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Illumina, Inc.    ILMN   US4523271090

ILLUMINA, INC. (ILMN)

32
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/11/2014 04/14/2014 04/15/2014 04/16/2014 04/17/2014 Date
135.24(c) 131.94(c) 131.05(c) 136.22(c) 135.45(c) Last
3 214 477 2 276 152 2 394 067 1 906 700 1 082 350 Volume
-0.37% -2.44% -0.67% +3.95% -0.57% Change
More quotes
Company
Illumina, Inc. develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function. It provides a comprehensive line of genetic analysis solutions with products and services that serve a broad range of highly interconnected markets,... 
Surperformance© rating of Illumina, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1 679 M
EBIT 2014 435 M
Net income 2014 228 M
Finance 2014 16,6 M
Yield 2014 -
Sales 2015 1 985 M
EBIT 2015 556 M
Net income 2015 299 M
Finance 2015 3,37 M
Yield 2015 -
PER 2014 79,66
PER 2015 65,65
EV / Sales 2014 10,4x
EV / Sales 2015 8,81x
Capitalization 17 487 M
More Financials
Latest news on ILLUMINA, INC.
1d ago WALL STREET WEEK AHEAD : Spring fever brings hope for U.S. earnings
2d ago ILLUMINA : Bolsters Product Portfolio to Support Oncology Clinical Research and ..
3d agoILLUMINA, INC. : quaterly earnings release
04/11 ILLUMINA : MiSeq Maintenance Sought by Health and Human Services
04/10 ILLUMINA : Combine Solicitation - Yearly Maintenance of Illumina MiSeq
04/09 ILLUMINA : CONTRACT AWARD - Notice of Intent to Negotiate a Sole Source Contract
04/09 ILLUMINA : TruSeq Reagents and Consumables Sought by Health and Human Services
04/08 ILLUMINA : $40,910 Federal Contract Awarded to Illumina
04/08 ILLUMINA : Adds to Product Portfolio to Support Oncology Clinical Research and D..
04/07 ILLUMINA : CONTRACT AWARD - Notice of Intent to Negotiate a Sole Source Contract
04/07 ILLUMINA : to Announce First Quarter 2014 Financial Results on Tuesday, April 22..
04/02 ILLUMINA : "Methods for Reducing Nucleic Acid Damage" in Patent Application Appr..
More news
4-Traders Strategies on ILLUMINA, INC. 
2013End of the technical recovery
More Strategies
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
Illumina, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Illumina, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF